Jeffrey K Tobias Insider Trading $NGSX NeurogesX Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey K Tobias.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey K Tobias. Jeffrey K Tobias is Chief Medical Officer in NeurogesX Inc ($NGSX) and CMO, EVP Research & Deve in NeurogesX Inc ($NGSX) and EVP Research & Dev & CMO in NeurogesX Inc ($NGSX).
Jeffrey K Tobias in NeurogesX Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey K Tobias: CMO, EVP Research & Deve, EVP Research & Dev & CMO, Chief Medical Officer
Holdings: 4,999 shares
Latest Transaction: Sep 20 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jeffrey K Tobias in NeurogesX Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | CMO, EVP Research & ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| May 19 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.82 | 1,115 | 3,144 | 4,999 | 6.1 K to 5 K (-18.24 %) |
| May 19 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.73 | 1,333 | 3,639 | 6,114 | 7.4 K to 6.1 K (-17.90 %) |
| May 16 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.84 | 1,333 | 3,786 | 7,447 | 8.8 K to 7.4 K (-15.18 %) |
| May 16 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.81 | 733 | 2,060 | 7,447 | 8.2 K to 7.4 K (-8.96 %) |
| May 16 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Sell | S | 2.91 | 600 | 1,746 | 8,180 | 8.8 K to 8.2 K (-6.83 %) |
| Apr 29 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Option Exercise | A | 3.29 | 75,000 | 246,750 | 75,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Option Exercise | A | 5.06 | 125,000 | 632,500 | 125,000 | |
| Feb 07 2011 | NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev ... | Option Exercise | A | 5.06 | 25,000 | 126,500 | 25,000 | |
| Jan 19 2010 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | A | 7.10 | 50,000 | 355,000 | 50,000 | |
| Dec 07 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | A | 8.32 | 1,000 | 8,320 | 1,000 | |
| Dec 01 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | M | 1.25 | 12,077 | 15,096 | 38,000 | |
| Dec 01 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Sell | S | 8.07 | 12,077 | 97,494 | 6,665 | 18.7 K to 6.7 K (-64.44 %) |
| Dec 01 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Buy | M | 1.25 | 12,077 | 15,096 | 18,742 | 6.7 K to 18.7 K (+181.20 %) |
| Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | M | 1.25 | 620 | 775 | 50,077 | |
| Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | M | 1.25 | 9,303 | 11,629 | 50,697 | |
| Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Sell | S | 8.27 | 620 | 5,130 | 6,665 | 7.3 K to 6.7 K (-8.51 %) |
| Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Buy | M | 1.25 | 620 | 775 | 7,285 | 6.7 K to 7.3 K (+9.30 %) |
| Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Sell | S | 8.38 | 9,303 | 77,976 | 6,665 | 16 K to 6.7 K (-58.26 %) |
| Nov 30 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Buy | M | 1.25 | 9,303 | 11,629 | 15,968 | 6.7 K to 16 K (+139.58 %) |
| Jan 20 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | A | 1.25 | 30,000 | 37,500 | 30,000 | |
| Jan 20 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | A | 1.25 | 60,000 | 75,000 | 60,000 | |
| Jan 14 2008 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | A | 5.43 | 25,000 | 135,750 | 25,000 |
Page: 1